Stock data

聯合 (4129)

聯合 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$472.19M, down 7.2% from a year earlier. EPS over the last four quarters totals NT$5.72.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 聯合 in Insightr